Research has established that VAT contributes to metabolic dysregulation, primarily through its role in insulin resistance and the secretion of various inflammatory factors, including interleukin-6 (IL-6) and C-reactive protein (CRP). The gene discussed is IL6; the disease is Insulin resistance.